Company Encyclopedia
View More
name
WHYY
002107.SZ
Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. It offers tablets, hard capsules, granules, and pills. The company also produces and sells oral liquids, mixtures, wine, tinctures, decoctions, and syrups, as well as patent medicines; and provides pharmaceutical technology consulting services.
3.159 T
002107.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
PharmaceuticalsIndustry
Industry Ranking62/223
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE11.26%B
    • Profit Margin9.55%B
    • Gross Margin77.74%A
  • Growth ScoreB
    • Revenue YoY5.45%C
    • Net Profit YoY219.21%A
    • Total Assets YoY-1.13%D
    • Net Assets YoY-0.08%C
  • Cash ScoreB
    • Cash Flow Margin1047.54%B
    • OCF YoY5.45%C
  • Operating ScoreB
    • Turnover0.83B
  • Debt ScoreB
    • Gearing Ratio27.21%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    WHYY released its performance for the first three quarters, with a net profit attributable to the parent company of 63.995 million yuan, an increase of 179.34%

    WHYY released its third-quarter report for 2025, with operating revenue for the first three quarters amounting to 625 million yuan, a year-on-year increase of 8.31%. The net profit attributable to the parent company was 63.995 million yuan, a year-on-year increase of 179.34%; the net profit after deducting non-recurring gains and losses was 61.2711 million yuan, a year-on-year increase of 187.87%. The basic earnings per share were 0.11 yuan

    Zhitong·
    SZ
    002107
    -4.76%
    Zhitong·
    SZ
    002107
    -4.76%

    WHYY: Directors plan to reduce holdings by 0.44%

    WHYY announced that director and board secretary Zhang Ge holds 10.0588 million shares of the company, accounting for 1.74% of the total share capital. He plans to reduce his holdings by no more than 2.5147 million shares, accounting for 0.44% of the total share capital, within three months after 15 trading days from the date of this announcement, through centralized bidding. The shares to be reduced come from his holdings prior to the company's initial public offering and from historical bonus shares, with the reduction price to be determined by the market price at that time

    Zhitong·
    SZ
    002107
    -4.76%
    Zhitong·
    SZ
    002107
    -4.76%

    11 companies disclosed their semi-annual reports for 2025, only WHYY saw an increase in holdings from QFII on a quarter-on-quarter basis

    As of July 24, 2025, 11 companies have disclosed their semi-annual reports for 2025. Among them, Changchuan Technology, Haitong Development, Minshida, and 2 other companies have received increased positions from institutions, with Changchuan Technology's increase exceeding 4 percentage points. Only WHYY has seen an increase from qualified foreign institutional investors, with the QFII shareholding ratio reaching 1.09%

    Zhitong·
    SZ
    002107
    -4.76%
    Zhitong·
    SZ
    002107
    -4.76%

    The first batch of semi-annual reports from the Shenzhen Stock Exchange has been released, with four companies showing "double growth" in performance

    The first batch of semi-annual reports from the Shenzhen Stock Exchange has been released, with WHYY, FOCUS LIGHTINGS, RAYHOO MOTOR DIES, CCTech, and *ST Lingda reporting their performance. Except for *ST Lingda, the other four companies achieved positive growth in both revenue and net profit. Among them, WHYY had the highest year-on-year increase in net profit, reaching 303.16%, with a revenue of 425 million yuan and a net profit of 44.6764 million yuan, and will distribute a cash dividend of 1.20 yuan for every 10 shares

    Zhitong·
    SZ
    300604
    -2.14%
    SZ
    002107
    -4.76%
    SZ
    300708
    +5.15%
    Zhitong·
    SZ
    300604
    -2.14%
    SZ
    002107
    -4.76%
    SZ
    300708
    +5.15%

    WHYY released its semi-annual performance report, with a net profit attributable to the parent company of 44.68 million yuan, a year-on-year increase of 303.16%

    WHYY released its 2025 semi-annual report, with revenue of 425 million yuan, a year-on-year increase of 7.64%; net profit attributable to shareholders of 44.68 million yuan, a year-on-year increase of 303.16%; net profit excluding non-recurring items of 42.74 million yuan, a year-on-year increase of 334.8%; basic earnings per share of 0.08 yuan. The company plans to distribute a cash dividend of 1.20 yuan for every 10 shares to all shareholders. Revenue from cardiovascular drugs was 294.2304 million yuan, a year-on-year increase of 11.53%

    Zhitong·
    SZ
    002107
    -4.76%
    Zhitong·
    SZ
    002107
    -4.76%
    © 2025 Longbridge｜Disclaimer